US Stock MarketDetailed Quotes
SLNO Soleno Therapeutics
- 57.7800
- +3.1500+5.77%
Close Nov 22 16:00 ET
- 59.5900
- +1.8100+3.13%
Post 20:01 ET
2.49BMarket Cap-20709P/E (TTM)
57.9400High54.6350Low595.17KVolume55.0000Open54.6300Pre Close33.72MTurnover2.13%Turnover RatioLossP/E (Static)43.12MShares59.753752wk High9.41P/B1.61BFloat Cap26.380052wk Low--Dividend TTM27.90MShs Float742.5000Historical High--Div YieldTTM6.05%Amplitude0.8500Historical Low56.6590Avg Price1Lot Size
Soleno Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -135.72%-14.93M | -217.12%-17.65M | -86.21%-12.53M | -20.01%-24.94M | -22.77%-6.31M | -36.00%-6.33M | -20.48%-5.57M | -5.75%-6.73M | 25.17%-20.78M | 25.06%-5.14M |
| Net income from continuing operations | -605.42%-76.62M | -157.86%-21.85M | -156.08%-21.4M | -62.00%-38.99M | -105.91%-11.3M | -77.12%-10.86M | -26.02%-8.48M | -45.98%-8.36M | 22.14%-24.07M | -93.99%-5.49M |
| Operating gains losses | ---- | ---- | ---- | 706.67%182K | -47,100.00%-470K | 32,750.00%653K | ---- | ---- | 94.09%-30K | 100.72%1K |
| Depreciation and amortization | 2.04%500K | 1.02%494K | 0.00%490K | -0.31%1.96M | 0.20%489K | -0.41%490K | -0.61%489K | -0.41%490K | 0.05%1.96M | -0.81%488K |
| Other non cash items | -9.20%987K | 320.20%1.71M | 19.34%469K | 819.19%3.04M | 318.86%1.15M | 432.84%1.09M | -40.99%406K | 149.81%393K | 4.74%-422K | 83.90%-525K |
| Change In working capital | 5,526.53%5.51M | -598.64%-4.04M | 1,600.88%1.94M | 487.30%2.93M | 852.96%1.91M | -1.01%98K | 127.81%811K | 111.90%114K | 34.15%-756K | 83.62%-253K |
| -Change in prepaid assets | -189.38%-101K | 579.55%299K | 124.25%81K | -840.71%-837K | -194.64%-660K | 3,666.67%113K | -80.00%44K | -392.98%-334K | 181.29%113K | 50.88%-224K |
| -Change in payables and accrued expense | 525.61%2.43M | -887.93%-4.83M | 195.19%3.87M | 192.12%1.54M | 225.83%190K | -38.35%-570K | 467.07%613K | 238.62%1.31M | -177.32%-1.68M | 80.57%-151K |
| -Change in other current liabilities | 769.37%1.93M | -50.34%-436K | -208.70%-100K | 640.43%762K | 372.32%738K | 40.51%222K | -835.48%-290K | 2,966.67%92K | -10.16%-141K | 0.00%-271K |
| -Change in other working capital | 278.08%1.26M | 107.88%923K | -100.10%-1.91M | 54.17%1.46M | 316.54%1.64M | -4.86%333K | 32.93%444K | -633.85%-954K | 441.88%947K | 585.19%393K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -135.72%-14.93M | -217.12%-17.65M | -86.21%-12.53M | -20.01%-24.94M | -22.77%-6.31M | -36.00%-6.33M | -20.48%-5.57M | -5.75%-6.73M | 25.17%-20.78M | 25.06%-5.14M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 4.04M | -120.92M | -115.24M | 0 | 0 | 0 | 0 | 0 | 40.91%-13K | 53.85%-6K |
| Net PPE purchase and sale | ---191K | ---8K | ---11K | --0 | --0 | --0 | --0 | --0 | 40.91%-13K | 53.85%-6K |
| Net investment purchase and sale | --4.23M | ---120.91M | ---115.23M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --4.04M | ---120.92M | ---115.24M | --0 | --0 | --0 | --0 | --0 | 40.91%-13K | 53.85%-6K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -94.23%2.28M | 795.36%152.75M | 938K | 1,177.46%180.02M | 123.56M | 11,420.76%39.4M | 6,149.65%17.06M | 0 | 11,109.38%14.09M | 0 |
| Net common stock issuance | -122.18%-637K | ---- | ---- | 877.15%137.86M | --117.93M | 739.77%2.87M | ---- | ---- | --14.11M | --0 |
| Proceeds from stock option exercised by employees | -92.03%2.91M | --3.16M | --938K | --42.16M | --5.63M | --36.53M | --0 | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 86.67%-16K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -94.23%2.28M | 795.36%152.75M | --938K | 1,177.46%180.02M | --123.56M | 11,420.76%39.4M | 6,149.65%17.06M | --0 | 11,109.38%14.09M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 194.42%57.02M | 444.16%42.85M | 1,062.04%169.68M | -31.46%14.6M | 165.49%52.44M | -19.52%19.37M | -72.82%7.87M | -31.46%14.6M | -56.72%21.3M | -29.92%19.75M |
| Current changes in cash | -126.04%-8.61M | 23.34%14.18M | -1,785.17%-126.83M | 2,413.92%155.08M | 2,377.02%117.24M | 866.55%33.07M | 334.14%11.49M | -187.72%-6.73M | 76.00%-6.7M | 25.17%-5.15M |
| End cash Position | -7.67%48.41M | 194.42%57.02M | 444.16%42.85M | 1,062.04%169.68M | 1,062.04%169.68M | 165.49%52.44M | -19.52%19.37M | -72.82%7.87M | -31.46%14.6M | -31.46%14.6M |
| Free cash flow | -138.74%-15.12M | -217.27%-17.66M | -86.37%-12.54M | -19.94%-24.94M | -22.63%-6.31M | -36.00%-6.33M | -20.29%-5.57M | -5.75%-6.73M | 25.18%-20.79M | 25.12%-5.15M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data